Welcome to LookChem.com Sign In|Join Free

CAS

  • or

26707-60-8

Post Buying Request

26707-60-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

26707-60-8 Usage

Description

(2β,3β)-2,3-Dihydroxy-olean-12-en-28-oic acid is a triterpenoid compound belonging to the oleanane-type triterpenoids. It is a natural product derived from plants such as Olea europaea, Camellia japonica, and Isodon japonicus. (2β,3β)-2,3-Dihydroxy-olean-12-en-28-oic acid has demonstrated a range of biological activities, including anti-inflammatory, anti-tumor, and anti-microbial properties. Additionally, it has shown potential as an antioxidant and is being studied for its possible applications in treating diabetes and cardiovascular diseases. Its diverse pharmacological activities have made it a subject of interest for research in pharmaceuticals and medicine.

Uses

Used in Pharmaceutical and Medicinal Applications:
(2β,3β)-2,3-Dihydroxy-olean-12-en-28-oic acid is used as a bioactive compound for its potential therapeutic effects in various conditions. Its anti-inflammatory properties make it a candidate for treating inflammatory diseases, while its anti-tumor activities suggest its use in cancer therapy. The anti-microbial properties indicate its potential use in combating microbial infections, and its antioxidant capabilities point to its possible role in preventing oxidative stress-related disorders.
Used in Diabetes Treatment:
(2β,3β)-2,3-Dihydroxy-olean-12-en-28-oic acid is used as a potential treatment for diabetes due to its ability to modulate glucose metabolism and improve insulin sensitivity, which can help in managing blood sugar levels.
Used in Cardiovascular Disease Management:
(2β,3β)-2,3-Dihydroxy-olean-12-en-28-oic acid is used as a potential therapeutic agent for cardiovascular diseases, leveraging its antioxidant properties to protect against oxidative stress, which is a contributing factor to the development of such conditions.
Used in Antioxidant Formulations:
(2β,3β)-2,3-Dihydroxy-olean-12-en-28-oic acid is used as an antioxidant in various formulations to combat oxidative stress and protect cells from damage, which can contribute to the prevention and treatment of a range of diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 26707-60-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,7,0 and 7 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 26707-60:
(7*2)+(6*6)+(5*7)+(4*0)+(3*7)+(2*6)+(1*0)=118
118 % 10 = 8
So 26707-60-8 is a valid CAS Registry Number.

26707-60-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Augustic acid

1.2 Other means of identification

Product number -
Other names 2β,3β-dihydroxyolean-12-en-28-oic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:26707-60-8 SDS

26707-60-8Relevant articles and documents

Straightforward partial synthesis of four diastereomeric 2,3-dihydroxy-olean-12-en-28-oic acids from oleanolic acid

Sommerwerk, Sven,Heller, Lucie,Serbian, Immo,Csuk, René

, p. 8528 - 8534 (2016/02/03)

The four diastereomeric 2,3-dihydroxy-olean-12-en-28-oic acids (maslinic, augustic, bredemolic and 3-epi-maslinic acid) were easily accessed from one single starting material, oleanolic acid. The procedures allow the medium-to-large scale preparation of these valuable starting materials. Except for maslinic acid, the triterpenoic acids showed only a low cytotoxicity towards several human tumor cell lines.

Convenient and chromatography-free partial syntheses of maslinic acid and augustic acid

Sommerwerk, Sven,Csuk, René

, p. 5156 - 5158 (2014/12/11)

A convenient and chromatography-free 4-step synthesis of analytically pure maslinic acid (1, 41.2%) from oleanolic acid has been developed. Slight variations in the final steps gave an excellent yield of isomeric augustic acid (7, 71.9%).

Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents

Parra, Andres,Martin-Fonseca, Samuel,Rivas, Francisco,Reyes-Zurita, Fernando J.,Medina-O'Donnell, Marta,Martinez, Antonio,Garcia-Granados, Andres,Lupia?ez, Jose A.,Albericio, Fernando

, p. 278 - 301 (2014/02/14)

A broad set of potential bioactive conjugate compounds has been semi-synthesized through solution- and solid-phase organic procedures, coupling two natural pentacyclic triterpene acids, oleanolic (OA) and maslinic acids (MA), at the hydroxyl groups of the A-ring of the triterpene skeleton, with 10 different acyl groups. These acyl OA and MA derivatives have been tested for their anti-proliferative (against the b16f10 murine melanoma cancer cells) and antiviral (as inhibitors of the HIV-1-protease) effects. Several derivatives have shown high levels of early and total apoptosis (up to 90%). Most of the compounds that exhibited anti-proliferative effects also generated ROS, probably involving the activation of an intrinsic apoptotic route. The only four compounds that did not cause the release of ROS could be related to the participation of a probable extrinsic activation of the apoptosis mechanism. A great number of these acyl OA and MA derivatives have proved to be potent inhibitors of the HIV-1-protease, the most active inhibitors having IC 50 values between 0.31 and 15.6 μM, these values being between 4 and 186 times lower than their non-acylated precursors. The potent activities exhibited in the apoptosis-activation processes and in the inhibition of the HIV-1-protease by some OA and MA acylated derivatives imply that these compounds could be used as new, safe, and effective anticancer and/or antiviral drugs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 26707-60-8